Linda M Bonnekoh, Marius Gruber, Cathrine Thams, Kira Flinkenflügel, Susanne Meinert, Janik Goltermann, Dominik Grotegerd, Julia Hubbert, Judith Krieger, Christoph Jurischka, Ruth H Fellmeth, Nils R Winter, Tim Hahn, Elisabeth J Leehr, Nils Opel, Marc Pawlitzki, Paula Rehm, Nina V Werthern, Sharmili Edwin Thanarajah, Stefanie Fischer, Kira F Ahrens, Andreas Reif, Frederike Stein, Florian Thomas-Odenthal, Paula Usemann, Lea Teutenberg, Henry Staub, Hannah Meinert, Nina Alexander, Hamidreza Jamalabadi, Andreas Jansen, Martijn P van den Heuvel, Igor Nenadić, Benjamin Straube, Georg Romer, Tilo Kircher, Udo Dannlowski, Jonathan Repple
{"title":"Structural connectomic signatures of childhood maltreatment across affective and psychotic disorders.","authors":"Linda M Bonnekoh, Marius Gruber, Cathrine Thams, Kira Flinkenflügel, Susanne Meinert, Janik Goltermann, Dominik Grotegerd, Julia Hubbert, Judith Krieger, Christoph Jurischka, Ruth H Fellmeth, Nils R Winter, Tim Hahn, Elisabeth J Leehr, Nils Opel, Marc Pawlitzki, Paula Rehm, Nina V Werthern, Sharmili Edwin Thanarajah, Stefanie Fischer, Kira F Ahrens, Andreas Reif, Frederike Stein, Florian Thomas-Odenthal, Paula Usemann, Lea Teutenberg, Henry Staub, Hannah Meinert, Nina Alexander, Hamidreza Jamalabadi, Andreas Jansen, Martijn P van den Heuvel, Igor Nenadić, Benjamin Straube, Georg Romer, Tilo Kircher, Udo Dannlowski, Jonathan Repple","doi":"10.1016/j.euroneuro.2025.09.009","DOIUrl":null,"url":null,"abstract":"<p><p>Exposure to childhood maltreatment (CM) is a crucial risk factor for affective disorders and schizophrenia, which are linked to structural brain network alterations. We hypothesized a significant association between CM and brain structural connectivity in a transdiagnostic sample. Participants included patients with major depressive disorder (n = 827), bipolar disorder (n = 134), schizophrenia spectrum disorders (n = 118), and healthy controls (n = 932) aged 18-65 from the Marburg-Muenster Affective Disorders Cohort Study. Structural brain networks were reconstructed from structural and diffusion-weighted MRI. CM was assessed using the Childhood Trauma Questionnaire (CTQ) based on established cut-offs. Analyses of covariance investigated the main effect of CM and the interaction of diagnosis and CM on global network metrics. In addition, network-based statistic (NBS) analyses were performed to identify the underlying subnetworks. History of CM was positively associated with the number of connections (p<sub>FDR</sub>=0.01; CM: 95 %-CI=[533.9; 540.6], No CM: 95 %-CI=[529.1; 535.0]), normalized (p<sub>FDR</sub>=0.02; CM: 95 %-CI=[0.860; 0.863], No CM: 95 %-CI=[0.857; 0.860]) and non-normalized network efficiency (p<sub>FDR</sub>=0.01; CM: 95 %-CI=[0.405; 0.407], No CM: 95 %-CI=[0.403; 0.405]) and negatively associated with normalized network clustering (p<sub>FDR</sub>=0.045; CM: 95 %-CI=[4.976; 5.065], No CM: 95 %-CI=[5.100; 5.150]). There were no significant interaction effects of CM and diagnosis. NBS analyses revealed a large network of edges, in which individuals with CM exhibited higher structural connectivity compared to those without, which persisted after correcting for diagnosis. These findings indicate a connectome signature of CM, marked by hyperconnectivity, across major mental disorders and in healthy individuals, suggesting that CM affects connectome architecture independent of present psychiatric diagnoses.</p>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"100 ","pages":"42-52"},"PeriodicalIF":6.7000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Neuropsychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.euroneuro.2025.09.009","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/13 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Exposure to childhood maltreatment (CM) is a crucial risk factor for affective disorders and schizophrenia, which are linked to structural brain network alterations. We hypothesized a significant association between CM and brain structural connectivity in a transdiagnostic sample. Participants included patients with major depressive disorder (n = 827), bipolar disorder (n = 134), schizophrenia spectrum disorders (n = 118), and healthy controls (n = 932) aged 18-65 from the Marburg-Muenster Affective Disorders Cohort Study. Structural brain networks were reconstructed from structural and diffusion-weighted MRI. CM was assessed using the Childhood Trauma Questionnaire (CTQ) based on established cut-offs. Analyses of covariance investigated the main effect of CM and the interaction of diagnosis and CM on global network metrics. In addition, network-based statistic (NBS) analyses were performed to identify the underlying subnetworks. History of CM was positively associated with the number of connections (pFDR=0.01; CM: 95 %-CI=[533.9; 540.6], No CM: 95 %-CI=[529.1; 535.0]), normalized (pFDR=0.02; CM: 95 %-CI=[0.860; 0.863], No CM: 95 %-CI=[0.857; 0.860]) and non-normalized network efficiency (pFDR=0.01; CM: 95 %-CI=[0.405; 0.407], No CM: 95 %-CI=[0.403; 0.405]) and negatively associated with normalized network clustering (pFDR=0.045; CM: 95 %-CI=[4.976; 5.065], No CM: 95 %-CI=[5.100; 5.150]). There were no significant interaction effects of CM and diagnosis. NBS analyses revealed a large network of edges, in which individuals with CM exhibited higher structural connectivity compared to those without, which persisted after correcting for diagnosis. These findings indicate a connectome signature of CM, marked by hyperconnectivity, across major mental disorders and in healthy individuals, suggesting that CM affects connectome architecture independent of present psychiatric diagnoses.
期刊介绍:
European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.